{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:08:43Z","timestamp":1780088923357,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["SUBZ.C260.22.056"],"award-info":[{"award-number":["SUBZ.C260.22.056"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s13555-022-00701-5","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T21:02:26Z","timestamp":1646946146000},"page":"899-909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?"],"prefix":"10.1007","volume":"12","author":[{"given":"Piotr K.","family":"Krajewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servando E.","family":"Marr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Tomas Aragones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Gilaberte-Calzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"issue":"2","key":"701_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bjd.15251","volume":"176","author":"CJ Apfelbacher","year":"2017","unstructured":"Apfelbacher CJ, Nelson PA. Patient-reported outcome measures and qualitative research in dermatology: the quest for authenticity. Br J Dermatol. 2017;176(2):285\u20137.","journal-title":"Br J Dermatol"},{"key":"701_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1200\/EDBK_200383","volume":"38","author":"E Basch","year":"2018","unstructured":"Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122\u201334.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"701_CR3","first-page":"901","volume":"71","author":"D Dimitrov","year":"2017","unstructured":"Dimitrov D, Szepietowski JC. Instruments to assess stigmatization in dermatology. Postepy Hig Med Dosw (Online). 2017;71:901\u20135.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"1","key":"701_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/bjd.18711","volume":"183","author":"MX Shen","year":"2020","unstructured":"Shen MX, Chen X. Minimally important change: approach to interpretation of patient-reported outcomes. Br J Dermatol. 2020;183(1):8\u20139.","journal-title":"Br J Dermatol"},{"issue":"1","key":"701_CR5","first-page":"34","volume":"11","author":"PK Krajewski","year":"2021","unstructured":"Krajewski PK, Matusiak \u0141, von Stebut E, Schultheis M, Kirschner U, Nikolakis G, et al. Quality-of-life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients. Life (Basel). 2021;11(1):34.","journal-title":"Life (Basel)."},{"issue":"2","key":"701_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40271-016-0196-6","volume":"10","author":"C Copley-Merriman","year":"2017","unstructured":"Copley-Merriman C, Zelt S, Clark M, Gnanasakthy A. Impact of measuring patient-reported outcomes in dermatology drug development. Patient. 2017;10(2):203\u201313.","journal-title":"Patient"},{"key":"701_CR7","doi-asserted-by":"crossref","unstructured":"Mac Mahon J, Kirthi S, Byrne N, O\u2019Grady C, Tobin AM. An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa. Patient Relat Outcome Meas. 2020;11:21\u20136.","DOI":"10.2147\/PROM.S174299"},{"issue":"11","key":"701_CR8","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3390\/ijerph18116131","volume":"18","author":"PV Chernyshov","year":"2021","unstructured":"Chernyshov PV, Finlay AY, Tomas-Aragones L, Poot F, Sampogna F, Marron SE, et al. Quality of life in hidradenitis suppurativa: an update. Int J Environ Res Public Health. 2021;18(11):6131.","journal-title":"Int J Environ Res Public Health."},{"issue":"9","key":"701_CR9","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/jdv.15519","volume":"33","author":"PV Chernyshov","year":"2019","unstructured":"Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Svensson A, Manolache L, et al. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol. 2019;33(9):1633\u201343.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"701_CR10","unstructured":"Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. Dermatol Surg. 1989;729:39."},{"issue":"5","key":"701_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.15748","volume":"177","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017;177(5):1401\u20139.","journal-title":"Br J Dermatol"},{"issue":"5","key":"701_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/bjd.19565","volume":"184","author":"N Goldfarb","year":"2021","unstructured":"Goldfarb N, Lowes MA, Butt M, King T, Alavi A, Kirby JS. Hidradenitis suppurativa area and severity index revised (HASI-R): psychometric property assessment. Br J Dermatol. 2021;184(5):905\u201312.","journal-title":"Br J Dermatol"},{"key":"701_CR13","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"701_CR14","doi-asserted-by":"crossref","unstructured":"Mattei PL, Corey KC, Kimball AB. Psoriasis area severity index (PASI) and the dermatology life quality index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014;28(3):333\u20137.","DOI":"10.1111\/jdv.12106"},{"issue":"2","key":"701_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/jdv.15223","volume":"33","author":"L Misery","year":"2019","unstructured":"Misery L, Seneschal J, Reguiai Z, Merhand S, Heas S, Huet F, et al. The impact of atopic dermatitis on sexual health. J Eur Acad Dermatol Venereol. 2019;33(2):428\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"701_CR16","doi-asserted-by":"crossref","unstructured":"Marron SE, Gomez-Barrera M, Tomas Aragones L, Goni-Navarro A, Vilarrasa-Rull E, Diaz-Diaz RM, et al. Quality of life in hidradenitis suppurativa: validation of the HSQoL-24. Acta Derm Venereol. 2021;101(8):adv00529.","DOI":"10.2340\/00015555-3905"},{"key":"701_CR17","doi-asserted-by":"crossref","unstructured":"Marr\u00f3n SE, G\u00f3mez-Barrera M, Tom\u00e1s-Aragon\u00e9s L, D\u00edaz D\u00edaz RM, Vilarrasa Rull E, Madrid \u00c1lvarez MB, et al. Development and preliminary validation of the HSQoL-24 tool to assess quality of life in patients with hidradenitis suppurativa. Actas Dermosifiliogr (Engl Ed). 2019;110(7):554\u201360.","DOI":"10.1016\/j.adengl.2019.07.014"},{"issue":"1","key":"701_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","volume":"6","author":"R Sabat","year":"2020","unstructured":"Sabat R, Jemec GBE, Matusiak \u0141, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"701_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juh\u00e1sz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"701_CR20","doi-asserted-by":"crossref","unstructured":"Kirsten N, Petersen J, Hagenstr\u00f6m K, Augustin M. Epidemiology of hidradenitis suppurativa in Germany\u2014an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol. 2020;34(1):174\u20139.","DOI":"10.1111\/jdv.15940"},{"issue":"4","key":"701_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596\u2013601.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"701_CR22","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/bjd.16603","volume":"183","author":"\u0141 Matusiak","year":"2020","unstructured":"Matusiak \u0141. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol. 2020;183(6):e171\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"701_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90(3):264\u20138.","journal-title":"Acta Derm Venereol"},{"key":"701_CR24","doi-asserted-by":"crossref","unstructured":"G\u0142owaczewska A, Szepietowski JC, Matusiak \u0141. Prevalence and associated factors of alexithymia in patients with hidradenitis suppurativa: a cross-sectional study. Acta Derm Venereol. 2021;101(11):adv00598.","DOI":"10.2340\/actadv.v101.370"},{"issue":"1","key":"701_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","volume":"138","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Cohen AD, Gislason GH, Jemec GBE, Egeberg A. Increased suicide risk in patients with hidradenitis suppurativa. J Invest Dermatol. 2018;138(1):52\u20137.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"701_CR26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2014.530","volume":"135","author":"FJ Dalgard","year":"2015","unstructured":"Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984\u201391.","journal-title":"J Invest Dermatol"},{"key":"701_CR27","doi-asserted-by":"crossref","unstructured":"W\u0142odarek K, G\u0142owaczewska A, Matusiak \u0141, Szepietowski JC. Psychosocial burden of hidradenitis suppurativa patients\u2019 partners. J Eur Acad Dermatol Venereol. 2020;34(8):1822\u20137.","DOI":"10.1111\/jdv.16255"},{"key":"701_CR28","doi-asserted-by":"crossref","unstructured":"Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149(1):211\u20133.","DOI":"10.1046\/j.1365-2133.2003.05390.x"},{"key":"701_CR29","doi-asserted-by":"crossref","unstructured":"Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157(12):846\u201355.","DOI":"10.7326\/0003-4819-157-12-201212180-00004"},{"issue":"6","key":"701_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1046\/j.1365-2133.2002.05031.x","volume":"147","author":"TS Housman","year":"2002","unstructured":"Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB Jr, Balkrishnan R. Use of the self-administered eczema area and severity index by parent caregivers: results of a validation study. Br J Dermatol. 2002;147(6):1192\u20138.","journal-title":"Br J Dermatol"},{"issue":"12","key":"701_CR31","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","volume":"140","author":"CR Charman","year":"2004","unstructured":"Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective. Arch Dermatol. 2004;140(12):1513\u20139.","journal-title":"Arch Dermatol"},{"issue":"8","key":"701_CR32","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/jid.2013.138","volume":"133","author":"L Chularojanamontri","year":"2013","unstructured":"Chularojanamontri L, Griffiths CE, Chalmers RJ. The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol. 2013;133(8):1956\u201362.","journal-title":"J Invest Dermatol"},{"key":"701_CR33","doi-asserted-by":"crossref","unstructured":"Senthilnathan A, Kolli SS, Cardwell LA, Richardson I, Feldman SR, Pichardo RO. Validation of a hidradenitis suppurativa self-assessment tool. J Cutan Med Surg. 2019;23(4):388\u201390.","DOI":"10.1177\/1203475419839965"},{"issue":"4","key":"701_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","volume":"154","author":"C Cusack","year":"2006","unstructured":"Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154(4):726\u20139.","journal-title":"Br J Dermatol"},{"issue":"5","key":"701_CR35","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/bjd.13502","volume":"172","author":"IE Deckers","year":"2015","unstructured":"Deckers IE, Mihajlovi\u0107 D, Prens EP, Boer J. Hidradenitis suppurativa: a pilot study to determine the capability of patients to self-assess their Hurley stage. Br J Dermatol. 2015;172(5):1418\u20139.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00701-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00701-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00701-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:06:19Z","timestamp":1650535579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00701-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00701-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}